<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T23:59:58Z</responseDate>
  <request identifier="oai:figshare.com:article/33987558" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33987558</identifier>
        <datestamp>2026-09-24T17:27:57Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Multidrug-resistant pattern of &lt;i&gt;S. aureus&lt;/i&gt; isolates.&lt;/p&gt;</dc:title>
          <dc:creator>Mavis S. Nyakayoya (25104999)</dc:creator>
          <dc:creator>Dennis Chisala (25105002)</dc:creator>
          <dc:creator>Kennedy Lubundi (25105005)</dc:creator>
          <dc:creator>Hariet Milambo (25105008)</dc:creator>
          <dc:creator>Masiliso A. Liamba (25105011)</dc:creator>
          <dc:creator>Kesaobaka Batisani (25105014)</dc:creator>
          <dc:creator>David Chisompola (22298349)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>≥ 60 years</dc:subject>
          <dc:subject>provincial referral hospital</dc:subject>
          <dc:subject>mansa general hospital</dc:subject>
          <dc:subject>mannitol salt agar</dc:subject>
          <dc:subject>continued local surveillance</dc:subject>
          <dc:subject>bauer disk diffusion</dc:subject>
          <dc:subject>used oral antibiotics</dc:subject>
          <dc:subject>reducing treatment effectiveness</dc:subject>
          <dc:subject>higher odds compared</dc:subject>
          <dc:subject>suspected staphylococcal skin</dc:subject>
          <dc:subject>soft tissue infections</dc:subject>
          <dc:subject>dnase tests ).</dc:subject>
          <dc:subject>staphylococcus aureus &lt;/</dc:subject>
          <dc:subject>limited susceptibility testing</dc:subject>
          <dc:subject>1 %, 48</dc:subject>
          <dc:subject>antimicrobial susceptibility testing</dc:subject>
          <dc:subject>year retrospective study</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>4 %, 28</dc:subject>
          <dc:subject>5 %), ciprofloxacin</dc:subject>
          <dc:subject>7 %), erythromycin</dc:subject>
          <dc:subject>overall mrsa prevalence</dc:subject>
          <dc:subject>aureus &lt;/</dc:subject>
          <dc:subject>4 %),</dc:subject>
          <dc:subject>antimicrobial susceptibility</dc:subject>
          <dc:subject>staphylococcal infections</dc:subject>
          <dc:subject>retrospective cross</dc:subject>
          <dc:subject>reduced susceptibility</dc:subject>
          <dc:subject>limited settings</dc:subject>
          <dc:subject>lactam antibiotics</dc:subject>
          <dc:subject>higher mdr</dc:subject>
          <dc:subject>complicating treatment</dc:subject>
          <dc:subject>aor 4</dc:subject>
          <dc:subject>antimicrobial resistance</dc:subject>
          <dc:subject>266 ).</dc:subject>
          <dc:subject>182 ).</dc:subject>
          <dc:subject>study highlights</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>sectional study</dc:subject>
          <dc:subject>trimoxazole due</dc:subject>
          <dc:subject>treated empirically</dc:subject>
          <dc:subject>surrogate marker</dc:subject>
          <dc:subject>specimen source</dc:subject>
          <dc:subject>significant predictors</dc:subject>
          <dc:subject>poses challenges</dc:subject>
          <dc:subject>patient type</dc:subject>
          <dc:description>&lt;p&gt;Multidrug-resistant pattern of &lt;i&gt;S. aureus&lt;/i&gt; isolates.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-24T17:27:50Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pgph.0007348.t004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Multidrug-resistant_pattern_of_i_S_aureus_i_isolates_p_/33987558</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
